State Medicaid Spending on Anti-Obesity Drugs

Pennsylvania ranked third in per-beneficiary spending on the anti-obesity drugs known as GLP-1s in the year ended Oct. 31. The top five states ranked by per-beneficiary spending are shown. The drugs include Wegovy, Zepbound, and others. Total spending is in millions.